Press Release

Veracyte to Participate in Upcoming Investor Conferences

May 15, 2024

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 15, 2024-- Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, today announced it will participate in the following investor conferences.

  • Leerink Partners 2024 Healthcare Crossroads ConferenceAustin, TX
    Fireside Chat on May 29th at 12:20 p.m. Eastern Time
  • William Blair 44th Annual Growth Stock ConferenceChicago, IL
    Presentation on June 4th at 5:40 p.m. Eastern Time

Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at A replay of the webcasts will be available following the conclusion of the live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit or follow us on LinkedIn or X (Twitter).

Shayla Gorman
(619) 393-1545

Tracy Morris
(650) 380-4413

Source: Veracyte, Inc.